Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Total Non-Current Liabilities (2024)

Kairos Pharma's Total Non-Current Liabilities history spans 1 years, with the latest figure at $992000.0 for Q4 2024.

  • For Q4 2024, Total Non-Current Liabilities changed N/A year-over-year to $992000.0; the TTM value through Dec 2024 reached $992000.0, changed N/A, while the annual FY2024 figure was $992000.0, N/A changed from the prior year.
  • Total Non-Current Liabilities reached $992000.0 in Q4 2024 per KAPA's latest filing, down from $1.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.7 million in Q3 2024 to a low of $992000.0 in Q4 2024.